CN101903049B - 包囊的肾组织 - Google Patents

包囊的肾组织 Download PDF

Info

Publication number
CN101903049B
CN101903049B CN200880121614.8A CN200880121614A CN101903049B CN 101903049 B CN101903049 B CN 101903049B CN 200880121614 A CN200880121614 A CN 200880121614A CN 101903049 B CN101903049 B CN 101903049B
Authority
CN
China
Prior art keywords
tissue
polymer
beads
bead
kidney
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN200880121614.8A
Other languages
English (en)
Chinese (zh)
Other versions
CN101903049A (zh
Inventor
C·S·布恩苏西索
D·C·科尔特
B·C·克雷默
A·西达
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johnson and Johnson Medical SAS
Original Assignee
Ethicon SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethicon SAS filed Critical Ethicon SAS
Publication of CN101903049A publication Critical patent/CN101903049A/zh
Application granted granted Critical
Publication of CN101903049B publication Critical patent/CN101903049B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
    • A61L27/3645—Connective tissue
    • A61L27/365—Bones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Vascular Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CN200880121614.8A 2007-12-20 2008-12-17 包囊的肾组织 Expired - Fee Related CN101903049B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1532807P 2007-12-20 2007-12-20
US61/015328 2007-12-20
PCT/US2008/087211 WO2009085850A2 (en) 2007-12-20 2008-12-17 Encapsulated kidney tissue

Publications (2)

Publication Number Publication Date
CN101903049A CN101903049A (zh) 2010-12-01
CN101903049B true CN101903049B (zh) 2014-08-13

Family

ID=40524488

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200880121614.8A Expired - Fee Related CN101903049B (zh) 2007-12-20 2008-12-17 包囊的肾组织

Country Status (9)

Country Link
US (3) US8734527B2 (enExample)
EP (1) EP2231209B1 (enExample)
JP (1) JP5456692B2 (enExample)
CN (1) CN101903049B (enExample)
AU (1) AU2008343193B2 (enExample)
BR (1) BRPI0821540B1 (enExample)
CA (1) CA2708959C (enExample)
PL (1) PL2231209T3 (enExample)
WO (1) WO2009085850A2 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9125906B2 (en) 2005-12-28 2015-09-08 DePuy Synthes Products, Inc. Treatment of peripheral vascular disease using umbilical cord tissue-derived cells
PL2231209T3 (pl) 2007-12-20 2019-08-30 Ethicon, Incorporated Enkapsulowana tkanka nerkowa
US8236538B2 (en) 2007-12-20 2012-08-07 Advanced Technologies And Regenerative Medicine, Llc Methods for sterilizing materials containing biologically active agents
WO2012154186A1 (en) * 2011-05-12 2012-11-15 Empire Technology Development Llc Bioreactor for engineered tissue
US9555007B2 (en) 2013-03-14 2017-01-31 Massachusetts Institute Of Technology Multi-layer hydrogel capsules for encapsulation of cells and cell aggregates
DE202013012287U1 (de) 2013-04-23 2016-01-18 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Gelbildendes System zum Entfernen von Nierensteinfragmenten
EP2796101B1 (de) 2013-04-23 2016-04-20 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Kit zum Herstellen eines vernetzten Gels zum Umschließen von Nierensteinen und/oder Nierensteinfragmenten
EP2796100B1 (de) 2013-04-23 2016-04-20 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Gelbildendes System zum Entfernen von Nierensteinfragmenten
DE202013012275U1 (de) 2013-04-23 2015-12-18 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Kit zum Herstellen eines vernetzten Gels zum Umschließen von Nierensteinen und/oder Nierensteinfragmenten
WO2017161180A1 (en) * 2016-03-18 2017-09-21 Intrexon Corporation Compositions and methods for treatment of type vii collagen deficiencies
DE102017220710A1 (de) * 2017-11-20 2019-05-23 Aesculap Ag Implantat und Kit zum Behandeln und/oder biologischen Rekonstruieren eines Knochendefekts
WO2021040874A1 (en) * 2019-08-28 2021-03-04 Massachusetts Institute Of Technology In vitro tissue plate
JP2024544399A (ja) 2021-12-17 2024-11-29 メドスキン ソリューションズ ドクター スベラック アクチェンゲゼルシャフト 粉末コーティングされた生体材料ベースの多孔質材料を含む組成物

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050226854A1 (en) * 2001-09-07 2005-10-13 Yair Reisner Therapeutic transplantation using developing, human or porcine, renal or hepatic, grafts
US20060251630A1 (en) * 2002-12-24 2006-11-09 An-Go-Gen Inc. Encapsulated cell therapy

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4352883A (en) * 1979-03-28 1982-10-05 Damon Corporation Encapsulation of biological material
US4352833A (en) * 1979-12-12 1982-10-05 Young, Prussin, Mgk, J.V. Adherent controlled release pesticides
EP0127989A3 (en) 1983-06-01 1986-03-26 Connaught Laboratories Limited Microencapsulation of living tissue and cells
JPS60258121A (ja) * 1984-05-24 1985-12-20 コノート　ラボラトリーズ　リミテツド 生きた組織や細胞のマイクロカプセル及びその製造方法
US5573934A (en) * 1992-04-20 1996-11-12 Board Of Regents, The University Of Texas System Gels for encapsulation of biological materials
US5908623A (en) * 1993-08-12 1999-06-01 Cytotherapeutics, Inc. Compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
US6984728B2 (en) * 1993-09-24 2006-01-10 Schering Corporation Recombinant infectious laryngotracheitis virus and uses thereof
EP0815212A1 (en) * 1995-03-03 1998-01-07 Metabolex, Inc. Novel encapsulation process by a gelling polymer
ATE309000T1 (de) * 1995-06-27 2005-11-15 Bavarian Nordic As Verkapselte zellen die virenpartikeln produzieren
US5888497A (en) * 1996-04-03 1999-03-30 The Rogosin Institute Agarose coated agarose beads containing cancer cells that produce material which suppresses cancer cell proliferation
AU5391401A (en) * 2000-04-28 2001-11-12 Sangamo Biosciences Inc Targeted modification of chromatin structure
ITMI20032115A1 (it) * 2003-11-03 2005-05-04 Uni Degli Dustdi Di Pavia Allestimento di sistemi di coltura tridimensionale in
CN1897890B (zh) * 2003-12-23 2012-01-25 Fmc生物聚合物联合股份有限公司 用藻酸盐基质控制细胞生长
PL2231209T3 (pl) * 2007-12-20 2019-08-30 Ethicon, Incorporated Enkapsulowana tkanka nerkowa
US8734257B2 (en) * 2011-09-30 2014-05-27 Igt Wager gaming voting leaderboard

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050226854A1 (en) * 2001-09-07 2005-10-13 Yair Reisner Therapeutic transplantation using developing, human or porcine, renal or hepatic, grafts
US20060251630A1 (en) * 2002-12-24 2006-11-09 An-Go-Gen Inc. Encapsulated cell therapy

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
Cell factories for fighting cancer;Gabriele Bergers et al.;《Nature Biotechnology》;20010131;第19卷;第20-21页 *
Continuous release of endostatin from microencapsulated engineered cells for tumor therapy;Tatsuhiro Joki et al.;《Nature Biotechnology》;20010131;第19卷;第35-39页 *
Long-Term Expression of Erythropoietin from Myoblasts Immobilized in Biocompatible and Neovascularized Microcapsules;G. Orive et al.;《Molecular Therapy》;20050601;第12卷(第2期);第283-289页 *
Neuroprotective gene therapy for Huntington’s disease, using polymer-encapsulated cells engineered to secrete human ciliary neurotrophic factor: results of a phase I study;Bloch J. et al.;《Hum Gene Ther》;20041031;第15卷(第10期);第968-975页 *
Secretion of erythropoietin from microencapsulated rat kidney cell:preliminary results;J.Koo et al.;《The International Journal of Artificial Organs》;19931231;第16卷(第7期);第557-560页 *

Also Published As

Publication number Publication date
US20140271778A1 (en) 2014-09-18
AU2008343193B2 (en) 2014-04-24
WO2009085850A3 (en) 2010-04-29
EP2231209A2 (en) 2010-09-29
WO2009085850A2 (en) 2009-07-09
US8734527B2 (en) 2014-05-27
US20090162411A1 (en) 2009-06-25
CA2708959A1 (en) 2009-07-09
BRPI0821540A2 (pt) 2015-06-16
BRPI0821540B1 (pt) 2018-07-24
AU2008343193A1 (en) 2009-07-09
PL2231209T3 (pl) 2019-08-30
JP5456692B2 (ja) 2014-04-02
CN101903049A (zh) 2010-12-01
US9579348B2 (en) 2017-02-28
CA2708959C (en) 2017-01-31
JP2011507875A (ja) 2011-03-10
EP2231209B1 (en) 2018-11-28
US20140248326A1 (en) 2014-09-04

Similar Documents

Publication Publication Date Title
CN101903049B (zh) 包囊的肾组织
US12029833B2 (en) Tissue scaffold materials for tissue regeneration and methods of making
Kwon et al. Injectable extracellular matrix hydrogel developed using porcine articular cartilage
US20050180957A1 (en) Method of using fibrin-bound angiogenic factors to stimulate vascularization of transplant site of encapsulated cells
Jay et al. Engineering of multifunctional gels integrating highly efficient growth factor delivery with endothelial cell transplantation
NZ539713A (en) Implantation of encapsulated biological materials for treating diseases
JP2022534787A (ja) ハイドロゲル微粒子の調整可能な分解
JP2016530252A (ja) 組成物および送達系
US10500154B2 (en) Injectable biocompatible composition
CN110743034A (zh) 一种内外协同治疗糖尿病溃疡的多功能水凝胶敷料及其制备方法和应用
US7781400B2 (en) Pharmaceutical compositions comprising dextran with a molecular weight of 1.0-100 KDA and processes for their preparation
Somo et al. Dual crosslinking of alginate outer layer increases stability of encapsulation system
Burke et al. Phase-changing citrate macromolecule combats oxidative pancreatic islet damage, enables islet engraftment and function in the omentum
ES2705225T3 (es) Tejido de riñón encapsulado
KR102047207B1 (ko) 염증성 또는 통증성 질환 치료를 위한 복합 약물 전달 제형 및 이것의 제조방법
JP2005325075A (ja) 架橋ゼラチンゲルを担体とする半月板損傷治療剤
JP2004331643A (ja) 細胞製剤
KR20050120712A (ko) 세포 제제
JPWO2008120741A1 (ja) 塩基性線維芽細胞増殖因子の徐放性製剤
CN119912711A (zh) β-环糊精修饰的明胶微球、负载去铁胺的β-环糊精修饰的明胶微球及制备方法和应用
Sidney et al. Investigation of localised delivery of diclofenac sodium from PLGA/PEG

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20140813